Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III comparison of NER1006 versus Moviprep for bowel cleansing before colonoscopy
2014-002185-78Phase 3Completed
- Sponsor
- Norgine
- Start
- Aug 2014
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised trial of polyethylene glycol plus ascorbate and macrogol (3 arms), sponsored by Norgine. Primary endpoint: Overall bowel cleansing success rate. Started Aug 2014; status: completed.
02
Drugs
polyethylene glycol plus ascorbatemacrogol
Beyond the preview
Go deeper on 2014-002185-78.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002185-78.